GO pathway analysis of DEGs between different myeloid subsets showed that TNF was uniformly and significantly upregulated in CD14+ Mono, IFN-act CD14+ Mono, and CD16+ Mono of patients with IgG4-RD (Figure 4D). Here, FCGR3A is linked to immunoglobulin G4-related sclerosing disease.